• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/37

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

37 Cards in this Set

  • Front
  • Back
TWO MAIN TYPES OF MOVEMENT
DISORDERS:
1. Hypokinetic
2. Hyperkinetic
MOVEMENT DISORDERS:
MAJOR CATEGORIES
____
 Parkinson’s disease
 Parkinson’s plus
syndromes
Hypokinetic
MOVEMENT DISORDERS:
MAJOR CATEGORIES
_____
 Dystonia & Dyskinesias
 Tremor
 Abnormal tone
 Myoclonus
Hyperkinetic
____ MOVEMENT DISORDERS:
MAJOR CAUSES
 Parkinson’s Disease
 Diffuse Lewy Body Disease
 Multiple Systems Atrophy (+/- Ataxia)
 Progressive Supranuclear Palsy
 Corticobasal Degeneration
 Vascular Parkinsonism
 Post Traumatic Parkinsonism
 Secondary (Toxin, Medication, Metabolic)
HYPOKINETIC
PARKINSONISMS
________
Usually Asymmetric
 Cardinal Signs
 Tremor
 Rigidity
 Bradykinesia
 Levodopa Responsive
 Later Findings
 Postural Instability
 Levodopa-unresponsive gait disorder
 Non Motor Features
IDIOPATHIC PARKINSON’S DISEASE
PARKINSONISMS

_____
 Unlike PD, Lewy Bodies rapidly spready
throughout the brain, including the cerebral
cortex
 Levodopa Responsive Parkinsonism
 Rapidly Progressive Dementia
 Hallucinations
DIFFUSE LEWY BODY DISEASE
PARKINSONISMS

______
 Early Postural Instability and Falls
 Parkinsonism
 Unresponsive to Levodopa
 “Stone Face”
Dementia
 Ocular Signs
PROGRESSIVE SUPRANUCLEAR PALSY:
PSP
PARKINSONISMS

_________
 Asymmetric Parkinsonism with Poor Response
to Levodopa
 Apraxia and Alien Limb
 Spasticity, Rigidity, Dystonia
 Gait and Balance Problems
 Dementia always occurs, but may be a late
feature
CORTICOBASAL DEGENERATION:
CBGB
PARKINSONISMS
_____
Cardinal Findings
 Parkinsonism
 Unresponsive to
Levodopa
 Autonomic Failure
Types
 Striato-Nigral Type
 Parkinsonism First
 Shy-Drager
Syndrome
 Low Blood Pressure
 Cerebellar Signs
 Corticospinal Tract
Signs
 Spasticity
 Autonomic Failure
First
 Olivo-pontocerebellar
Type
OPCA
 Ataxia First
MULTIPLE SYSTEMS ATROPHY:
MSA
PARKINSONISM
_____
 Haldol and other antipsychotic medications
cause symmetric findings that are
indistinguishable at times from Idiopathic
Parkinson’s Disease
 Reglan is a dopamine blocker and is an
important cause of Parkinsonism in elderly
patients
 Anti-nausea medication
DRUG RELATED PARKINSONISM
HYPERKINESIAS

HYPERKINESIAS AND DYSKINESIAS
 Dystonia
Tremor
Chorea & Ballismus
Myoclonus
Ataxia and Dysmetria
 Tics
Akathisia
 Restless Legs
bleh
HYPERKINESIAS

definition of Dystonia
“A neurologic syndrome characterized by
involuntary, sustained, patterned, and often
repetitive muscle contractions of opposing
muscles causing twisting movements and
abnormal postures.”
HYPERKINESIAS

______

Characteristics
 Sustained, patterned
muscle contractions
 Agonists and
Antagonists
Cli i l Fi di
Types
 Focal
 Face
 Blepharospasm
 Meige Syndrome
 Neck
 Clinical Findings
 Repetitive Twisting
or Squeezing
Movements
 Fixed Postures
 Cervical Dystonia
 Limbs
 Task Specific
Dystonias – writing,
musicians
 Generalized
DYSTONIA
HYPERKINESIAS

CAUSES OF ____
 Idiopathic (Most Cases)
 DRUG RELATED
 Antipsychotics and Reglan
 Genetic (DYT-1 Gene)
 Structural
 Trauma
 Stroke
 Multiple Rare Diseases
DYSTONIA
HYPERKINESIAS

TREATMENT FOR ____

 Artane, Valium, occasionally Baclofen
 Botulinum Toxin Injection
 Deep Brain Stimulation (Globus Pallidus
Interna)
DYSTONIA
HYPERKINETIC DISORDERS:

definition of ____

 Involuntary, rhythmic oscillatory movement
TREMOR
HYPERKINETIC DISORDERS:
TYPES OF TREMOR

 Resting Tremor
 Parkinsonism
 Essential Tremor
 Limbs, Head, Voice
 Midbrain Outflow Tremors
 Cerebellar Tremor
 Rubral Tremor
 MS
 Drug-induced
 Exaggerated Physiologic Tremor
 Caffeine, Medication Withdrawal
woo!
HYPERKINETIC DISORDERS:
______ TREMOR
 Very Common - Idiopathic
 UE Tremor with Posture and/or Action
 Bilateral, usually roughly symmetric
 Typically of Long-Standing Duration
 Other Areas May Be Involved
 Head or Jaw
 Voice
 Lower Extremities
 Tremor may produce disability, but often doesn’t
 No clear association with other diseases or
disorders
ESSENTIAL
TREATMENT OF ___
TREMOR
 Primidone
 Propanolol and other Beta Blockers
Deep Brain Stimulation (Thalamus)
 Tremors of some patients are quite
responsive to alcohol, and patients may
self-medicate
ESSENTIAL
HYPERKINETIC DISORDERS:
CHOREA & BALLISMUS
 _____
Ceaseless rapid, non-rhythmical, complex
body movements that look well coordinated
and purposeful but are, in fact, involuntary.
Chorea
HYPERKINETIC DISORDERS:
CHOREA & BALLISMUS

 _____
Violent movements of the limbs, as in chorea,
sometimes affecting only one side of the body
(hemiballismus).
Ballismus
HYPERKINETIC DISORDERS:
CHARACTERISTICS OF ____
Non-rhythmical
 Excessive Spontaneous Movements
 Irregular, Random, Brief and Abrupt
 Non-repetitive
 Flitting randomly from one body part to
another
 Purposeless, but may be disguised
 Facial grimacing and abnormal
respiratory sounds
CHOREA
HYPERKINETIC DISORDERS:
CHOREA -- CAUSES
 MEDICATIONS (e.g. ___ dyskinesia)
 Haldol, other antipsychotics
 Reglan is an important cause of tardive dyskinesia
 Huntington’s Disease (Genetic)
 Hemiballism (Stroke)
 Post-Infectious (Strep Infection)
tardive
HYPERKINETIC DISORDERS:
______
 Etiology:
 Gene defect (CAG trinucleotide repeat) on chr 4-
“anticipation”
 Each child of a person with Huntington's Disease has
a 50% chance of inheriting the HD disease causing
gene.
HUNTINGTON’S DISEASE
HYPERKINETIC DISORDERS:
_____

Epidemiology:
 Typically begins in mid-life, between the ages of 30
and 45, though onset may occur as early as the age
of two or as late as the 70s.
 Children who develop the juvenile form of the disease
rarely live to adulthood.
 HD affects males and females equally and affects all
ethnic and racial groups.
HUNTINGTON’S DISEASE
HYPERKINETIC DISORDERS:
_____– PROGRESSION
 Early symptoms: cognitive ability,mobility,
depression, mood swings, forgetfulness, speech
impairment, clumsiness, involuntary twitching and
lack of coordination.
 As the disease progresses, concentration and short
term memory diminish and involuntary movements
of the head, trunk and limbs increase.
 Walking, speaking and swallowing abilities
deteriorate until the individual becomes totally
dependent.
 usually progresses over a 10-25 year period; fatal.
HUNTINGTON’S DISEASE
_____- MEDICATIONS
 Neuroleptics
 - Haloperidol, fluphenazine, risperidone,
thiothixene, thioridazine, clozapine, quetiapine
 Benzodiazepines
 - Clonazepam, Diazepam
 NMDA agonist
 - Amantadine
 DA receptor blockers
 - Reserpine, tetrabenazine
CHOREA
HYPERKINETIC DISORDERS:
_____
 Not a Tremor
 Sudden, shock-like muscle contractions
 Focal, Multifocal, or Generalized
 Usually irregular and jerky
 But may be regular and rhythmic
 Can be triggered by light, sound, threat,
startle
Example: body jerks just prior to falling asleep
MYOCLONUS
HYPERKINETIC DISORDERS:
_____
 Semi-voluntary (e.g. suppressible), rapid,nonrythmic
movements or sounds
 Background of normal activity
 Associated Compulsions
 May be associated with OCD
 Occasionally tics are disabling, but the OCD is
usually the more disabling condition, if it
exists
 Treat with neuroleptics
TICS
______

 Motor restlessness with a “desire to move”
 Difficult for patients to describe
 “I feel like I’m always crawling out of my skin”
 Often with associated vocalizations and
grunting
 Often very disabling
 Cause: MEDICATIONS – antipsychotics and
Metoclopromide (Reglan)
AKATHISIA
______

 Bothersome urge to move legs at night
 Prevents sleep
 Medications
 carbidopa-levodopa, opioids ,Benzodiazapenes,
Neurontin
 The FDA recently approved Ropinorole (Requip)
and Pramipexole (Mirapex).
RESTLESS LEGS
_____
(POST DOPAMINE-BLOCKADE) MOVEMENT
DISORDERS
PREVENTION
 Dopamine Depleting Agents
 Difficult now to Obtain in the U.S.
 Life Long Botulinum Toxin Injections
Deep Brain Stimulation
TARDIVE DYSKINESIA
COMPLICATIONS OF ____
BLOCKING AGENTS
 Reversible? Sequelae Include
 Tremor
 Parkinsonism
 Permanent and Difficult to Treat Sequelae
Include
 Tardive Dyskinesia (Chorea-like syndrome)
 Tardive Akathisia
 Tardive Dystonia (Long Term Botox, may
need DBS)
DOPAMINE
_____:
APPLICATIONS
 PD
 Dystonia
 Essential Tremor
 Tourette’s and Severe OCD
 Cluster HA’s
 Intractable pain
 Side effect: lowered BP
 *Clinical trials: Epilepsy & Depression
 *Other psychiatric disorders (Europe)
DEEP BRAIN STIMULATION
______

 Helps to:
 Control motor fluxuations
 Manage dyskinesias
 Control tremors
 Reduce medications
 Pain
 Does not help:
 gait and balance
 PD patients should not expect DBS to improve
any symptoms beyond their best “on” time
DEEP BRAIN STIMULATION (DBS)
MOVEMENT DISORDERS SUMMARY

PD
Parkinson's Plus syndromes
Iatrogenic
Toxic
Hypokinetic
MOVEMENT DISORDERS SUMMARY

Akathisia - restlessness
Athetosis - writhing
Ballismus - Lightning-like
Chorea - dancing, non-rhythmic
Dystonia - co-contractions
Myoclonus - sudden jerks
Tics - Compulsive, repetitive
Tremors - shaking, rhythmic
Hyperkinetic